Holen Sie sich die Stockscreener-App
9.61
2.67%
0.25
Handel nachbörslich:
9.61
Schlusskurs vom Vortag:
$9.36
Offen:
$9.37
24-Stunden-Volumen:
226.92K
Relative Volume:
0.83
Marktkapitalisierung:
$317.91M
Einnahmen:
$65.42M
Nettoeinkommen (Verlust:
$-32.96M
KGV:
-7.5669
EPS:
-1.27
Netto-Cashflow:
$-19.87M
1W Leistung:
+5.49%
1M Leistung:
+7.61%
6M Leistung:
-19.38%
1J Leistung:
+35.35%
1-Tages-Spanne:
$9.27
$9.77
1-Wochen-Bereich:
$8.8833
$9.77
52-Wochen-Spanne:
$5.45
$18.98
Neuropace Inc Stock (NPCE) Company Profile
Firmenname
Neuropace Inc
Sektor
Branche
Telefon
(650) 237-2700
Adresse
455 N. BERNARDO AVENUE, MOUNTAIN VIEW
Vergleichen Sie NPCE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NPCE
Neuropace Inc
|
9.61 | 302.36M | 65.42M | -32.96M | -19.87M | -1.27 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Neuropace Inc Stock (NPCE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-28 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-21 | Eingeleitet | UBS | Buy |
| 2024-03-14 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-08-24 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2023-02-22 | Eingeleitet | Lake Street | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-01-19 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-01-07 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-18 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-05-17 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-05-17 | Eingeleitet | SVB Leerink | Outperform |
| 2021-05-17 | Eingeleitet | Wells Fargo | Overweight |
Alle ansehen
Neuropace Inc Aktie (NPCE) Neueste Nachrichten
NeuroPace Inc. stock trendline breakdownJuly 2025 Outlook & AI Optimized Trade Strategies - Newser
Can NeuroPace Inc. hit a new high this monthWeekly Risk Report & AI Forecast for Swing Trade Picks - Newser
Nantahala Capital Management LLC Lowers Stake in NeuroPace, Inc. $NPCE - MarketBeat
Statistical indicators supporting NeuroPace Inc.’s strengthTreasury Yields & Safe Capital Growth Tips - Newser
NeuroPace, Inc. $NPCE Stock Holdings Increased by Walleye Capital LLC - MarketBeat
Will NeuroPace Inc. see short term momentum2025 Top Decliners & Reliable Price Breakout Alerts - Newser
What to expect from NeuroPace Inc. in the next 30 daysMarket Sentiment Report & AI Forecast for Swing Trade Picks - Newser
How to use Fibonacci retracement on NeuroPace Inc.Trade Volume Report & Advanced Swing Trade Entry Plans - Newser
Published on: 2025-09-03 01:50:13 - Newser
Custom strategy builders for tracking NeuroPace Inc.Dividend Hike & Low Drawdown Trading Strategies - Newser
What candlestick patterns are forming on NeuroPace Inc.July 2025 Closing Moves & Safe Swing Trade Setup Alerts - Newser
Volume spikes in NeuroPace Inc. stock – what they mean2025 Fundamental Recap & High Accuracy Swing Trade Signals - Newser
Can NeuroPace Inc. stock double in the next yearJuly 2025 Highlights & Target Return Focused Picks - khodrobank.com
Building trade automation scripts for NeuroPace Inc.Trade Ideas & Fast Moving Stock Watchlists - Newser
Ghisallo Capital Management LLC Makes New $2.46 Million Investment in NeuroPace, Inc. $NPCE - MarketBeat
Armistice Capital LLC Raises Stake in NeuroPace, Inc. $NPCE - MarketBeat
How to monitor NeuroPace Inc. with trend dashboards2025 Biggest Moves & Free Reliable Trade Execution Plans - Newser
Driehaus Capital Management LLC Buys New Position in NeuroPace, Inc. $NPCE - MarketBeat
Will NeuroPace Inc. stock recover after earnings2025 Pullback Review & Accurate Buy Signal Alerts - khodrobank.com
Can NeuroPace Inc. outperform in the next rallyEarnings Growth Summary & Low Risk High Win Rate Picks - khodrobank.com
Russell Investments Group Ltd. Takes $552,000 Position in NeuroPace, Inc. $NPCE - MarketBeat
Candlestick Reversal Detected on NeuroPace Inc.’s Chart2025 Investor Takeaways & Low Risk Growth Stock Ideas - beatles.ru
S P Trends: Does NeuroPace Inc. have high return on assetsCPI Data & Daily Volume Surge Signals - khodrobank.com
What MACD and RSI say about NeuroPace Inc.Trade Analysis Summary & Free High Return Stock Watch Alerts - Newser
What are analysts’ price targets for NeuroPace Inc.July 2025 Rallies & Low Volatility Stock Recommendations - khodrobank.com
How cyclical is NeuroPace Inc.’s revenue streamQuarterly Portfolio Report & High Conviction Buy Zone Alerts - khodrobank.com
Can NeuroPace Inc. maintain sales growthJuly 2025 Update & Real-Time Market Trend Scan - khodrobank.com
Is NeuroPace Inc. stock reversal real or fakeAnalyst Downgrade & Weekly Watchlist for Hot Stocks - Newser
Multi factor analysis applied to NeuroPace Inc.Chart Signals & High Win Rate Trade Alerts - Newser
NeuroPace, Inc. Reports Record Revenue and Strong Margins in Q2 2025 Earnings Call - TipRanks
Will NeuroPace Inc. bounce back from current supportJuly 2025 Price Swings & Capital Efficiency Focused Strategies - Newser
Price momentum metrics for NeuroPace Inc. explained2025 Price Momentum & Long-Term Safe Return Strategies - Newser
Real Time Data Flags Unusual Activity in NeuroPace Inc.2025 Technical Patterns & Community Verified Trade Alerts - beatles.ru
NeuroPace Inc. stock daily chart insightsPortfolio Gains Report & Safe Swing Trade Setups - Newser
Finanzdaten der Neuropace Inc-Aktie (NPCE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Neuropace Inc-Aktie (NPCE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Morrell Martha | CHIEF MEDICAL OFFICER |
Feb 21 '25 |
Sale |
13.72 |
78,334 |
1,074,844 |
81,993 |
| KCK LTD. | 10% Owner |
Feb 20 '25 |
Sale |
9.40 |
5,270,845 |
49,545,943 |
0 |
| Morrell Martha | CHIEF MEDICAL OFFICER |
Jan 30 '25 |
Sale |
15.00 |
200 |
3,000 |
86,762 |
| Morrell Martha | CHIEF MEDICAL OFFICER |
Jan 29 '25 |
Sale |
15.00 |
100 |
1,500 |
86,962 |
0.38%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):